ask="1.20"
ask_size="1000"
average_daily_volume="248397"
bid="1.08"
bid_size="1400"
book_value="1.35"
change="-0.06"
change_from_200_day_moving_average="-2.62"
change_from_50_day_moving_average="-0.83"
change_from_52_week_high="-8.43"
change_From_52_week_low="0.07"
change_in_percent="-4.96%"
close="1.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.32"
ebitda="0.00"
eps_estimate_current_year="-0.32"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.34"
ex_dividend_date="N/A"
float_shares="N/A"
high="1.21"
high_52_weeks="9.58"
last_trade_date="2/17/2017"
last_trade_price="1.15"
last_trade_size="100"
last_trade_time="4:00pm"
low="1.08"
low_52_weeks="1.08"
market_capitalization="13.86M"
moving_average_200_day="3.77"
moving_average_50_day="1.98"
name="Moleculin Biotech
Inc."
notes="N/A"
one_year_target_price="9.26"
open="1.21"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-69.52%"
percent_change_from_50_day_moving_average="-41.85%"
percent_change_from_52_week_high="-88.00%"
percent_change_from_52_week_low="+6.48%"
previous_close="1.21"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.90"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="12054000"
short_ratio="2.56"
stock_exchange="NCM"
symbol="MBRX"
volume="758895"
weeks_range_52="1.08 - 9.58"
